Abstract Library

#2025 Health-Related Quality of Life Determinants in Swedish Patients after Surgery for Small Intestinal Neuroendocrine Tumors

Introduction: Overall survival for patients with small intestinal neuroendocrine tumors (siNETs) is often long even with metastatic disease, making quality of life issues especially relevant. The impact of surgery on their quality of life is unknown.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Milanetto A, Nordenström E, Sundlöv A, Almquist M,

Keywords: health-related quality of life, small intestinal neuroendocrine tumor,

#1515 Pathomorphology of Sporadic Medullary Thyroid Carcinoma – A Retrospective Analysis for a Period of 10 Years

Introduction: Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor, often difficult for diagnosis both clinically and histologically.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Ivanova R, Karanova P, Videnov K, Sechanov T, Kanev N,

Keywords: medullary thyroid carcinoma, surgery, pathology,

#677 Care of NET Patients at the Skåne University Hospital-Lund University, Sweden: A Model for the Multidisciplinary Approach to the Diagnosis and Treatment of NET

Introduction: The varied and nonspecific symptoms of neuroendocrine tumors (NET) often delay diagnosis until the disease has progressed. Input from various medical specialties can improve access to and delivery of care.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Nordenstrom E

Authors: Nordenström E, Bergenfelz A, Ljungberg O, Tennvall J, Valdemarsson S,

Keywords: neuroendocrine tumor, multidisciplinary, fellowship,

#647 Reducing the Risk of Tuberculosis Reactivation when Administering Everolimus for a Pancreatic Neuroendocrine Tumor: A Case Report

Introduction: Everolimus can potentially reactivate tuberculosis (TB) through immunosuppression. This was recently reported to have occurred in a kidney transplant recipient. To date, no clear strategy has been developed for reducing the risk of TB reactivation during everolimus treatment.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Tamura T, Nakazuru S, Sakane S, Iwasaki R, Iwasaki T,

Keywords: everolimus, NET, LTBI,

#550 Predictors of Survival Following Y90 DOTATOC/DOTATATE Therapy

Introduction: Y90-DOTATATE and Y90-DOTATOC are established treatments for patients with advanced neuroendocrine tumours. Outcomes associated with improved survival following therapy are still unclear.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Gilbert T, Mckane G, Banks M, Poston G, Vora J,

Keywords: Y90 DOTATOC/DOTATATE, survival,